3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2/3
1
Phase 2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
12
Thoracic
2
Sarcoma
1
Plasma cell
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
118
Urinary Bladder Neoplasms
27
Carcinoma, Renal Cell
25
Kidney Neoplasms
19
Neoplasms
14
Neoplasm Metastasis
9
Breast Neoplasms
9
Non-Muscle Invasive Bladder Neoplasms
8
Prostatic Hyperplasia
5
Pain
5
Lung Neoplasms
5
Liver Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Melanoma
4
Carcinoma, Hepatocellular
4
Urologic Neoplasms
3
Stomach Neoplasms
3
Recurrence
3
Prostatic Neoplasms, Castration-Resistant
3
Multiple Myeloma
3
Kidney Diseases
3
Head and Neck Neoplasms
3
Carcinoma, Transitional Cell
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Tobacco Use Disorder
2
Small Cell Lung Carcinoma
2
Prostatic Diseases
2
Prostate Cancer Metastatic
2
Pancreatic Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Venous Thromboembolism
×
Genitourinary
×
Clear all
NCT03006562
2020-08-05
PREVENTER
Johns Hopkins University
Phase 4
Terminated
501 enrolled
13 charts